All -Trans-Retinoic Acid–induced pseudotumor cerebri in Acute Promyelocytic Leukemia

All -Trans-Retinoic Acid–induced pseudotumor cerebri in Acute Promyelocytic Leukemia

Absract All-trans-retinoic acid is an integral part in the treatment strategy of acute promyelocytic leukemia (APL) . Here we describe a case of pseudotumor cerebri associated with all-trans retinoic acid (ATRA ) during induction therapy in an adult with Acute Promylelocytic Leukemia (AP...

Full description

Bibliographic Details
Main Author:	anoop tm
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-08-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Acute Promylelocytic Leukemia All-trans-retinoic
Online Access:	https://mjhid.org/index.php/mjhid/article/view/1899

Similar Items

All-trans-retinoic acid–induced pseudotumor cerebri in acute promyelocytic leukemia
by: T. M. Anoop, et al.
Published: (2014-07-01)

All-trans-retinoic acid-induced pseudotumor cerebri in acute promyelocytic leukemia
by: T. M. Anoop, et al.
Published: (2014-01-01)

Scrotal ulceration following all-trans retinoic acid therapy for acute promyelocytic leukemia
by: Illias Tazi, et al.
Published: (2011-01-01)

All-Trans Retinoic Acid-Induced Ototoxicity During Chemotherapy in Pediatric Acute Promyelocytic Leukemia
by: Jong Hyeon Lee, et al.
Published: (2021-01-01)

Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide
by: Maryam Habibi, et al.
Published: (2021-04-01)

Effect of all-trans retinoic acid on newly diagnosed acute promyelocytic leukemia patients: results of a Brazilian center
by: B.C. de-Medeiros, et al.
Published: (1998-12-01)

Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis
by: Valeria Ferla, et al.
Published: (2020-04-01)

Acute promyelocytic leukemia: An experience on 95 Greek patients treated in the all-trans-retinoic acid era
by: Maria Pagoni
Published: (2014-08-01)

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2018-09-01)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
by: Francesco Autore, et al.
Published: (2021-07-01)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
by: McCulloch D, et al.
Published: (2017-03-01)

Treatment of adult patients with acute promyelocytic leukemia according to the AIDA protocol
by: E N Parovichnikova, et al.
Published: (2013-07-01)

A case of acute promyelocytic leukemia with morphologic multilineage dysplastic changes
by: Setsuki Isono, et al.
Published: (2013-02-01)

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
by: Etienne Paubelle, et al.
Published: (2019-05-01)

High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure
by: Morgan B. Smith, et al.
Published: (2014-01-01)

Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis
by: Renata Cabral, et al.
Published: (2014-11-01)

Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01)

Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01)

Treatment for acute promyelocytic leukemia during pregnancy
by: V V Troitskaia, et al.
Published: (2013-10-01)

Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy
by: Liang B, et al.
Published: (2017-04-01)

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01)

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy
by: Carmelo Gurnari, et al.
Published: (2021-01-01)

Genital Ulcer Development in Patients with Acute Promyelocytic Leukaemia Treated with All-Trans Retinoic Acid: A Case Series
by: Mohammed Al Huneini, et al.
Published: (2013-05-01)

Acute Promyelocytic Leukemia during Pregnancy: A Systematic Review of the Literature
by: Andrea Santolaria, et al.
Published: (2020-04-01)

Acute Promyelocytic Leukemia in Four Year Old Female Child - A Case Report
by: Anirudha V. Kushtagi, et al.
Published: (2014-07-01)

Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
by: Ida Sofie Grønningsæter, et al.
Published: (2019-10-01)

Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2
by: Károly Jambrovics, et al.
Published: (2020-03-01)

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
by: Håkon Reikvam, et al.
Published: (2017-09-01)

Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
by: Sebastian Klobuch, et al.
Published: (2018-11-01)

Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid
by: Maria Hernandez-Valladares, et al.
Published: (2021-04-01)

Advances in Pediatric Acute Promyelocytic Leukemia
by: Shannon E. Conneely, et al.
Published: (2020-02-01)

Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia
by: Xavier Thomas
Published: (2019-02-01)

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2020-01-01)

Blood Parameters in Treatment with Arsenic Trioxide in Acute Promyelocytic Leukemia: A Systematic Review
by: Mehdi Mohammadi Kanesbi, et al.
Published: (2020-04-01)

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
by: Jianai Sun, et al.
Published: (2020-11-01)

Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
by: Øystein Bruserud, et al.
Published: (2021-05-01)

Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patients
by: Hamed Ghaffari, et al.
Published: (2019-02-01)

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia
by: Mariam Fatima, et al.
Published: (2021-06-01)

All-trans Retinoic Acid Induced the Differentiation of Human Glioma Cells
by: Qing-xi Liu, et al.
Published: (2011-03-01)

Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report
by: Yan H, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_irie2sn4hus7san5g1prr4dd48